Ho-Young Huh

Ho-Young Huh

Net worth: 499 423 $ as of 2025-05-30

56 year
Health Technology
Consumer Services
Health Services

Profile

Ho-Young Huh was the founder of Rezolute, Inc. founded in 2010, serving as Vice Chairman from 2018 to 2019.
Dr. Huh is the founder of Konus Advisory Group, Inc. founded in 2012, serving as Managing Director from 2012 to 2014.
Dr. Huh is the founder of StemPar Sciences, Inc. founded in 2012, serving as Chairman since 2012.
Dr. Huh is the founder of pH Pharma Co., Ltd. founded in 2015, serving as Chief Executive Officer since 2015.
Dr. Huh was the founder of Peak Bio, Inc. founded in 2016, serving as Executive Chairman in 2024.
Dr. Huh is also the founder of Healthcare & Humanity Foundation.
Dr. Huh is currently Chief Executive Officer at Peak Bio Co. Ltd., Chairman at Pliant Therapeutics, Inc. since 2017, Chairman at Akari Therapeutics Plc since 2024, and Director at SciDose LLC, Interplast, SFJAZZ, and Resurge International.
Former positions include Chairman, President & Chief Executive Officer at BiPar Sciences, Inc. from 2008 to 2010; Chairman at Geron Corp.
from 2011 to 2018; Chairman at CytomX Therapeutics Holdings LLC; Chairman at Epizyme, Inc. from 2009 to 2012; Chairman at CytomX Therapeutics, Inc. from 2012 to 2018; Director at Nektar Therapeutics in 2009; Director at Calibra Medical LLC; Director at Abbott Biotherapeutics Corp.
in 2010; Non-Executive Director at Addex Therapeutics Ltd. from 2012 to 2014; Director at The Bay Area Bioscience Association; Independent Director at EOS SpA; Director at Synchronicity Pharma, Inc.; Director at Bionik Laboratories Corp.; Director at 4D Molecular Therapeutics, Inc.; Director at Ascendancy Healthcare, Inc.; Director at Eidos Therapeutics, Inc.; Partner at McKinsey & Co., Inc.; and Managing Partner at Quintessa Investment Co. Ltd. Education includes undergraduate studies at Dartmouth College and doctorate degrees from Weill Cornell Medical College and Cornell University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.1%
2026-06-14 45,924 ( 0.1% ) 299 567 $ 2026-07-30
2026-06-10 99,759 ( 0.16% ) 103 749 $ 2026-07-30
2026-05-31 9,610,622,000 ( 6.86% ) 96 106 $ 2025-05-30

Ho-Young Huh active positions

CompaniesPositionStart
PLIANT THERAPEUTICS, INC. Chairman 2018-04-30
AKARI THERAPEUTICS, PLC Chairman -
Director/Board Member -
Chief Executive Officer 2015-09-21
Chief Executive Officer -
Director/Board Member -
Founder 2011-12-31
Director/Board Member 2011-04-18
Director/Board Member 2011-04-18

Former positions of Ho-Young Huh

CompaniesPositionEnd
░░░░ ░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Ho-Young Huh's experience

Training of Ho-Young Huh

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Healthcare & Humanity Foundation

Commercial Services

Health Technology

Health Technology